Biblio Discovery — Demo Discovery Service

7 results for "Anthony Hauser"

Showing 1–7 · 1.72 seconds · RSS

  1. Journal Article Full text

    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe

    Anthony Hauser; Michel J. Counotte; Charles C. Margossian et al.

    PLOS Medicine, Vol. 17 No. 7 · 2020 · English · PLOS Scopus

    Background: As of 16 May 2020, more than 4.5 million cases and more than 300,000 deaths from disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported. Reliable estimates of mortality from SARS-CoV-2 infection are essential for understanding clinical…

  2. Journal Article Full text

    Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa

    Anthony Hauser; Katharina Kusejko; Leigh F. Johnson et al.

    PLOS Computational Biology, Vol. 15 No. 6 · 2019 · English · PLOS Scopus

    The scale-up of antiretroviral therapy (ART) in South Africa substantially reduced AIDS-related deaths and new HIV infections. However, its success is threatened by the emergence of resistance to non-nucleoside reverse-transcriptase inhibitors (NNRTI). The MARISA (Modelling Antiretroviral drug…

  3. Journal Article Full text

    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study

    Anthony Hauser; Katharina Kusejko; Leigh F. Johnson et al.

    PLOS Medicine, Vol. 17 No. 12 · 2020 · English · PLOS Scopus

    …age, would only slow down the increase in levels of NNRTI PDR. Anthony Hauser and co-workers model the implications of dolutegravir scale-up for drug resistance in antiretroviral treatment in South Africa. Why was this study done?: What did the researchers do and find?: What do these findings mean?:

  4. Journal Article Full text

    Assessing the potential impact of transmission during prolonged viral shedding on the effect of lockdown relaxation on COVID-19

    Burcu Tepekule; Anthony Hauser; Viacheslav N. Kachalov et al.

    PLOS Computational Biology, Vol. 17 No. 1 · 2021 · English · PLOS Scopus

    A key parameter in epidemiological modeling which characterizes the spread of an infectious disease is the generation time, or more generally the distribution of infectiousness as a function of time since infection. There is increasing evidence supporting a prolonged viral shedding window for…

  5. Journal Article Full text

    Bayesian workflow for time-varying transmission in stratified compartmental infectious disease transmission models

    Judith A. Bouman; Anthony Hauser; Simon L. Grimm et al.

    PLOS Computational Biology, Vol. 20 No. 4 · 2024 · English · PLOS Scopus

    Compartmental models that describe infectious disease transmission across subpopulations are central for assessing the impact of non-pharmaceutical interventions, behavioral changes and seasonal effects on the spread of respiratory infections. We present a Bayesian workflow for such models…

  6. Journal Article Full text

    Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level

    Viacheslav N. Kachalov; Huyen Nguyen; Suraj Balakrishna et al.

    PLOS Computational Biology, Vol. 17 No. 1 · 2021 · English · PLOS Scopus

    Beta-lactam- and in particular carbapenem-resistant Enterobacteriaceae represent a major public health threat. Despite strong variation of resistance across geographical settings, there is limited understanding of the underlying drivers. To assess these drivers, we developed a transmission model of…

  7. Journal Article Full text

    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis

    Diana Buitrago-Garcia; Aziz Mert Ipekci; Leonie Heron et al.

    PLOS Medicine, Vol. 19 No. 5 · 2022 · English · PLOS Scopus

    Background: Debate about the level of asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection continues. The amount of evidence is increasing and study designs have changed over time. We updated a living systematic review to address 3 questions: (1) Among people who…